1Markova N, kussovski V, Drandarska I, et al. Protective activity of Lentinan in experimental tuberculosis [ J ]. Int Immunopharmacol, 2003,3 ( 10-11 ) :1557-1562.
2Kimurq Y,Lijima S,Kato T,et al. TS-1 and lentinam combination immumochemotherapy for advanance or recurrentgastric cancer: a preliminary report [ J ]. Gan To Kagaka Ryoho, 2003,30 ( 11 ) : 1791-1793.
3Mushiake H,Tsunoda T, Nukatsuka M, et al. Dendritie cells might be one of key factors for eliating antitumor effect by chemoimmunotherapy in vivo [ J ]. Cancer Immunol Immunother, 2005,54 ( 2 ) : 120-128.
5CHEN Y, XIE M Y, NIE S P, ctal. Purification, composition analysis and antioxidant activity of a polysaccharide from the fruiting bodies of Ganoderma atrum[J]. Food Chemistry, 2008, 107(1): 231-241.
6ZHU X L, CHEN A F, LIN Z B. Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice[J]. Journal of Ethnopharmacology, 2007, 111(2): 219-226.
7XU L, CHEN H, XU H, et al. Anti-tumour and immuno-modulation effects of triptolide-loaded polymeric micelles[J]. European Journal of Pharmaceutics and Biopharmaceutics, 2008, 70(3): 741-748.
8S. P. Wasser. Medicinal mushrooms as a source of antitumor and im- munomodulating polysacch - arides [ J ]. Appl Microbiol Biotechnol, 60 (2002) 258 - 274.
9Nakano H. A multi - institutional prospective study of lentinan in ad- vanced gastric cancer patiie - nts with unreseetable and recurrent diseases:effect on prolongation of sur - vival and improveme - nt of quality of life. Kanagawa Lentinan Research Group[ J]. Hepat - o gas- troenterology. 1999, Jul - Aug,46 (28) : 2662 - 8.
